This study demonstrated that bupivacaine local anesthesia, compared to lidocaine alone, significantly reduces post-operative narcotic analgesic use in dermatologic surgery patients. The longer duration of action of bupivacaine provides extended post-operative pain control, resulting in decreased opioid consumption and improved patient comfort during the immediate post-operative period.

Bupivacaine provides significantly longer post-operative analgesia compared to lidocaine in dermatologic surgery.

Use of bupivacaine reduces post-operative narcotic analgesic use, supporting opioid-sparing pain management strategies.

Combining bupivacaine with lidocaine offers both rapid onset and prolonged duration of anesthesia.